X T L Biopharmaceuticals reported $-479000 in EBIT for its fiscal quarter ending in December of 2024.


Ebit Change Date
Alaunos Therapeutics USD -7949000 715K Dec/2023
Bioline Rx USD -3664000 1.72M Jun/2025
Teva Pharmaceutical Industries USD 406M 540M Jun/2025
X T L Biopharmaceuticals USD -479000 19K Dec/2024